VEGFA and ischemia: In conclusion, this study revealed that glycemic control and the level of ischemia in the macula at baseline may be associated with the short-term response to the first intravitreal anti-VEGF injection, and may help predict which patients with DME should be considered for a change to anti-inflammatory treatment.